Chinese Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2203636, encodeId=f02822036367a, content=偏重的研究方向：中药 经验分享：<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>咨询一下多长时间见刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7d9291885, createdName=ms9000000212374175, createdTime=Thu May 09 10:50:56 CST 2024, time=2024-05-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220868, encodeId=01b6122086879, content=偏重的研究方向：医学综合 经验分享：<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea585428031, createdName=ms6000000251788979, createdTime=Thu May 19 10:12:17 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886686, encodeId=ef4b88668678, content=审稿速度:3.0 偏重的研究方向：中医;中药 经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=1Im8bYNrNRT3KEJj0victoQ&s=100, createdBy=dac15080514, createdName=小程序下下代谢 , createdTime=Sat Sep 19 17:08:42 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801509, encodeId=9a3280150976, content=请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4395341133, createdName=ms9000000064142082, createdTime=Mon Jul 06 19:55:43 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205913, encodeId=a08c120591320, content=请问这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=879b89295, createdName=zhxl81920, createdTime=Fri Mar 25 18:15:54 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073661, encodeId=5e2910e366101, content=请问谁有参考文献endnote的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8e25428745, createdName=ms8000000070893075, createdTime=Wed Nov 24 22:45:07 CST 2021, time=2021-11-24, status=1, ipAttribution=)]

2024-05-09 ms9000000212374175 来自山东省

偏重的研究方向：中药
经验分享：#期刊论坛#咨询一下多长时间见刊？

6 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203636, encodeId=f02822036367a, content=偏重的研究方向：中药 经验分享：<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>咨询一下多长时间见刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7d9291885, createdName=ms9000000212374175, createdTime=Thu May 09 10:50:56 CST 2024, time=2024-05-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220868, encodeId=01b6122086879, content=偏重的研究方向：医学综合 经验分享：<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea585428031, createdName=ms6000000251788979, createdTime=Thu May 19 10:12:17 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886686, encodeId=ef4b88668678, content=审稿速度:3.0 偏重的研究方向：中医;中药 经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=1Im8bYNrNRT3KEJj0victoQ&s=100, createdBy=dac15080514, createdName=小程序下下代谢 , createdTime=Sat Sep 19 17:08:42 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801509, encodeId=9a3280150976, content=请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4395341133, createdName=ms9000000064142082, createdTime=Mon Jul 06 19:55:43 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205913, encodeId=a08c120591320, content=请问这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=879b89295, createdName=zhxl81920, createdTime=Fri Mar 25 18:15:54 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073661, encodeId=5e2910e366101, content=请问谁有参考文献endnote的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8e25428745, createdName=ms8000000070893075, createdTime=Wed Nov 24 22:45:07 CST 2021, time=2021-11-24, status=1, ipAttribution=)]

2023-10-30 ms6000000450980482 来自天津

想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展

33 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203636, encodeId=f02822036367a, content=偏重的研究方向：中药 经验分享：<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>咨询一下多长时间见刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7d9291885, createdName=ms9000000212374175, createdTime=Thu May 09 10:50:56 CST 2024, time=2024-05-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220868, encodeId=01b6122086879, content=偏重的研究方向：医学综合 经验分享：<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea585428031, createdName=ms6000000251788979, createdTime=Thu May 19 10:12:17 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886686, encodeId=ef4b88668678, content=审稿速度:3.0 偏重的研究方向：中医;中药 经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=1Im8bYNrNRT3KEJj0victoQ&s=100, createdBy=dac15080514, createdName=小程序下下代谢 , createdTime=Sat Sep 19 17:08:42 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801509, encodeId=9a3280150976, content=请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4395341133, createdName=ms9000000064142082, createdTime=Mon Jul 06 19:55:43 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205913, encodeId=a08c120591320, content=请问这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=879b89295, createdName=zhxl81920, createdTime=Fri Mar 25 18:15:54 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073661, encodeId=5e2910e366101, content=请问谁有参考文献endnote的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8e25428745, createdName=ms8000000070893075, createdTime=Wed Nov 24 22:45:07 CST 2021, time=2021-11-24, status=1, ipAttribution=)]

2022-05-03 ms5000001271611106

请问这个杂志需要原始数据吗，还是只要原图就行？

93 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203636, encodeId=f02822036367a, content=偏重的研究方向：中药 经验分享：<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>咨询一下多长时间见刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7d9291885, createdName=ms9000000212374175, createdTime=Thu May 09 10:50:56 CST 2024, time=2024-05-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220868, encodeId=01b6122086879, content=偏重的研究方向：医学综合 经验分享：<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea585428031, createdName=ms6000000251788979, createdTime=Thu May 19 10:12:17 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886686, encodeId=ef4b88668678, content=审稿速度:3.0 偏重的研究方向：中医;中药 经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=1Im8bYNrNRT3KEJj0victoQ&s=100, createdBy=dac15080514, createdName=小程序下下代谢 , createdTime=Sat Sep 19 17:08:42 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801509, encodeId=9a3280150976, content=请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4395341133, createdName=ms9000000064142082, createdTime=Mon Jul 06 19:55:43 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205913, encodeId=a08c120591320, content=请问这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=879b89295, createdName=zhxl81920, createdTime=Fri Mar 25 18:15:54 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073661, encodeId=5e2910e366101, content=请问谁有参考文献endnote的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8e25428745, createdName=ms8000000070893075, createdTime=Wed Nov 24 22:45:07 CST 2021, time=2021-11-24, status=1, ipAttribution=)]

2022-11-07 ms5000001761757413

请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用

81 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203636, encodeId=f02822036367a, content=偏重的研究方向：中药 经验分享：<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>咨询一下多长时间见刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7d9291885, createdName=ms9000000212374175, createdTime=Thu May 09 10:50:56 CST 2024, time=2024-05-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220868, encodeId=01b6122086879, content=偏重的研究方向：医学综合 经验分享：<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea585428031, createdName=ms6000000251788979, createdTime=Thu May 19 10:12:17 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886686, encodeId=ef4b88668678, content=审稿速度:3.0 偏重的研究方向：中医;中药 经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=1Im8bYNrNRT3KEJj0victoQ&s=100, createdBy=dac15080514, createdName=小程序下下代谢 , createdTime=Sat Sep 19 17:08:42 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801509, encodeId=9a3280150976, content=请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4395341133, createdName=ms9000000064142082, createdTime=Mon Jul 06 19:55:43 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205913, encodeId=a08c120591320, content=请问这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=879b89295, createdName=zhxl81920, createdTime=Fri Mar 25 18:15:54 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073661, encodeId=5e2910e366101, content=请问谁有参考文献endnote的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8e25428745, createdName=ms8000000070893075, createdTime=Wed Nov 24 22:45:07 CST 2021, time=2021-11-24, status=1, ipAttribution=)]

2022-05-19 ms6000000251788979

偏重的研究方向：医学综合
经验分享：#学习# 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题

96 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203636, encodeId=f02822036367a, content=偏重的研究方向：中药 经验分享：<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>咨询一下多长时间见刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7d9291885, createdName=ms9000000212374175, createdTime=Thu May 09 10:50:56 CST 2024, time=2024-05-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220868, encodeId=01b6122086879, content=偏重的研究方向：医学综合 经验分享：<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea585428031, createdName=ms6000000251788979, createdTime=Thu May 19 10:12:17 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886686, encodeId=ef4b88668678, content=审稿速度:3.0 偏重的研究方向：中医;中药 经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=1Im8bYNrNRT3KEJj0victoQ&s=100, createdBy=dac15080514, createdName=小程序下下代谢 , createdTime=Sat Sep 19 17:08:42 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801509, encodeId=9a3280150976, content=请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4395341133, createdName=ms9000000064142082, createdTime=Mon Jul 06 19:55:43 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205913, encodeId=a08c120591320, content=请问这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=879b89295, createdName=zhxl81920, createdTime=Fri Mar 25 18:15:54 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073661, encodeId=5e2910e366101, content=请问谁有参考文献endnote的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8e25428745, createdName=ms8000000070893075, createdTime=Wed Nov 24 22:45:07 CST 2021, time=2021-11-24, status=1, ipAttribution=)]

2020-09-19 小程序下下代谢

审稿速度:3.0
偏重的研究方向：中医;中药
经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice.

109 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203636, encodeId=f02822036367a, content=偏重的研究方向：中药 经验分享：<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>咨询一下多长时间见刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7d9291885, createdName=ms9000000212374175, createdTime=Thu May 09 10:50:56 CST 2024, time=2024-05-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220868, encodeId=01b6122086879, content=偏重的研究方向：医学综合 经验分享：<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea585428031, createdName=ms6000000251788979, createdTime=Thu May 19 10:12:17 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886686, encodeId=ef4b88668678, content=审稿速度:3.0 偏重的研究方向：中医;中药 经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=1Im8bYNrNRT3KEJj0victoQ&s=100, createdBy=dac15080514, createdName=小程序下下代谢 , createdTime=Sat Sep 19 17:08:42 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801509, encodeId=9a3280150976, content=请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4395341133, createdName=ms9000000064142082, createdTime=Mon Jul 06 19:55:43 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205913, encodeId=a08c120591320, content=请问这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=879b89295, createdName=zhxl81920, createdTime=Fri Mar 25 18:15:54 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073661, encodeId=5e2910e366101, content=请问谁有参考文献endnote的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8e25428745, createdName=ms8000000070893075, createdTime=Wed Nov 24 22:45:07 CST 2021, time=2021-11-24, status=1, ipAttribution=)]

2020-07-06 ms9000000064142082

请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？

151 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203636, encodeId=f02822036367a, content=偏重的研究方向：中药 经验分享：<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>咨询一下多长时间见刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7d9291885, createdName=ms9000000212374175, createdTime=Thu May 09 10:50:56 CST 2024, time=2024-05-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220868, encodeId=01b6122086879, content=偏重的研究方向：医学综合 经验分享：<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea585428031, createdName=ms6000000251788979, createdTime=Thu May 19 10:12:17 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886686, encodeId=ef4b88668678, content=审稿速度:3.0 偏重的研究方向：中医;中药 经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=1Im8bYNrNRT3KEJj0victoQ&s=100, createdBy=dac15080514, createdName=小程序下下代谢 , createdTime=Sat Sep 19 17:08:42 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801509, encodeId=9a3280150976, content=请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4395341133, createdName=ms9000000064142082, createdTime=Mon Jul 06 19:55:43 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205913, encodeId=a08c120591320, content=请问这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=879b89295, createdName=zhxl81920, createdTime=Fri Mar 25 18:15:54 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073661, encodeId=5e2910e366101, content=请问谁有参考文献endnote的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8e25428745, createdName=ms8000000070893075, createdTime=Wed Nov 24 22:45:07 CST 2021, time=2021-11-24, status=1, ipAttribution=)]

2024-03-25 ms4000000320228007 来自湖北省

版面费怎么收？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203636, encodeId=f02822036367a, content=偏重的研究方向：中药 经验分享：<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>咨询一下多长时间见刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7d9291885, createdName=ms9000000212374175, createdTime=Thu May 09 10:50:56 CST 2024, time=2024-05-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220868, encodeId=01b6122086879, content=偏重的研究方向：医学综合 经验分享：<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea585428031, createdName=ms6000000251788979, createdTime=Thu May 19 10:12:17 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886686, encodeId=ef4b88668678, content=审稿速度:3.0 偏重的研究方向：中医;中药 经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=1Im8bYNrNRT3KEJj0victoQ&s=100, createdBy=dac15080514, createdName=小程序下下代谢 , createdTime=Sat Sep 19 17:08:42 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801509, encodeId=9a3280150976, content=请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4395341133, createdName=ms9000000064142082, createdTime=Mon Jul 06 19:55:43 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205913, encodeId=a08c120591320, content=请问这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=879b89295, createdName=zhxl81920, createdTime=Fri Mar 25 18:15:54 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073661, encodeId=5e2910e366101, content=请问谁有参考文献endnote的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8e25428745, createdName=ms8000000070893075, createdTime=Wed Nov 24 22:45:07 CST 2021, time=2021-11-24, status=1, ipAttribution=)]

2022-03-25 zhxl81920

请问这个杂志收费吗

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2203636, encodeId=f02822036367a, content=偏重的研究方向：中药 经验分享：<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>咨询一下多长时间见刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f7d9291885, createdName=ms9000000212374175, createdTime=Thu May 09 10:50:56 CST 2024, time=2024-05-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2165685, encodeId=b1ad2165685fb, content=想咨询一下UNDER CONSIDERATION是个啥状态，已经有几天了，也没有进展, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25ea6423863, createdName=ms6000000450980482, createdTime=Mon Oct 30 10:27:55 CST 2023, time=2023-10-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1216563, encodeId=e38f121656368, content=请问这个杂志需要原始数据吗，还是只要原图就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88776387915, createdName=ms5000001271611106, createdTime=Tue May 03 14:29:05 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098916, encodeId=6e13209891604, content=请问大家现在审稿速度怎么样呀，能accept就行，见刊慢没事，着急毕业用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53b68417531, createdName=ms5000001761757413, createdTime=Mon Nov 07 09:04:27 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220868, encodeId=01b6122086879, content=偏重的研究方向：医学综合 经验分享：<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> 导师给了篇RCT，10年前的老数据，我整理了一下，昨天刚投CJA就被秒拒了，第一例患者纳入前没有注册，而是纳入后注册的，很多期刊对这个一票否决，我想问问有没有期刊能容忍这个问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea585428031, createdName=ms6000000251788979, createdTime=Thu May 19 10:12:17 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886686, encodeId=ef4b88668678, content=审稿速度:3.0 偏重的研究方向：中医;中药 经验分享：目前审稿速度很快，一审约在一个月内，四个审稿人给的大修，编辑也是大修。修了整整一个月时间，返回后首先格式审查，但是很奇怪，大修返回后半个月，状态一直是分配给编辑，之后就给出了接受，撕毁没有作者回复返回到审稿人手里。总体很快，审稿人很负责人，编辑nice., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=1Im8bYNrNRT3KEJj0victoQ&s=100, createdBy=dac15080514, createdName=小程序下下代谢 , createdTime=Sat Sep 19 17:08:42 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801509, encodeId=9a3280150976, content=请问一下，这个期刊支持两个通讯作者吗?在提交作者信息的时候只能标记一个，但是pubmed上还是有共同通讯的，有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4395341133, createdName=ms9000000064142082, createdTime=Mon Jul 06 19:55:43 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195235, encodeId=5233219523513, content=版面费怎么收？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f569208296, createdName=ms4000000320228007, createdTime=Mon Mar 25 15:18:18 CST 2024, time=2024-03-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205913, encodeId=a08c120591320, content=请问这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=879b89295, createdName=zhxl81920, createdTime=Fri Mar 25 18:15:54 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073661, encodeId=5e2910e366101, content=请问谁有参考文献endnote的格式？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8e25428745, createdName=ms8000000070893075, createdTime=Wed Nov 24 22:45:07 CST 2021, time=2021-11-24, status=1, ipAttribution=)]

2021-11-24 ms8000000070893075

请问谁有参考文献endnote的格式？

67 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务